Bausch & Lomb ZyLET Clears FDA

Loteprednol/tobramycin ophthalmic will be marketed by sales force that had been promoting the conjunctivitis agent Optivar.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet